| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Werewolf Therapeutics, Inc. (HOWL) has 4 insiders with recent SEC Form 4 filings, including 0 buys and 33 sells. HOWL is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 4.78M | $1.68M | - | |
| 10% | 4.78M | $1.68M | - | |
| Dir | 377.2K | $132.4K | -173,515 | |
| 10% | 361.2K | $126.8K | -678,226 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 17, 2025 | Evnin Luke55 | Director | Sell | 134,553 | $0.96 | $128,785.31 | -1.2% | -28.4% | - | |
| Nov 12, 2025 | Gadicke Ansbert85 | 10% Owner | Sell | 213,529 | $1.13 | $241,278.01 | -0.9% | -34.2% | - | |
| Nov 12, 2025 | Evnin Luke55 | Director | Sell | 137,041 | $1.13 | $154,850.07 | -0.9% | -34.2% | - | |
| Nov 12, 2025 | Mpm Bioventures 2014, L.P.67 | 10% Owner | Sell | 213,529 | $1.13 | $241,278.01 | -0.9% | -34.2% | - | |
| Nov 6, 2025 | Evnin Luke55 | Director | Sell | 155,885 | $1.22 | $189,830.23 | -1.3% | -46.5% | - | |
| Nov 6, 2025 | Mpm Bioventures 2014, L.P.67 | 10% Owner | Sell | 242,890 | $1.22 | $295,781.28 | -1.3% | -46.5% | - | |
| Nov 6, 2025 | Gadicke Ansbert85 | 10% Owner | Sell | 242,890 | $1.22 | $295,781.28 | -1.3% | -46.5% | - | |
| Nov 3, 2025 | Gadicke Ansbert85 | 10% Owner | Sell | 295,043 | $1.33 | $391,636.07 | -1.5% | -48.2% | - | |
| Nov 3, 2025 | Mpm Bioventures 2014, L.P.67 | 10% Owner | Sell | 295,043 | $1.33 | $391,636.07 | -1.5% | -48.2% | - | |
| Nov 3, 2025 | Evnin Luke55 | Director | Sell | 189,356 | $1.33 | $251,348.62 | -1.6% | -48.2% | - |